Insulin-like Growth Factor 1 (IGF-1)

Test investigation

Insulin-like Growth Factor 1 (IGF-1)

Laboratory offering test

NNUH

Units

nmol/L

Sample type

Serum

Turnaround times (TAT) Urgent/Routine/GP or OPD

10 working days

Reference intervals

Male (Female) nmol/L 0–1yr 1.7-18.1 (2.1-18.7) 1 yr 2.4-23.1 (2.5-21) 2 yr 3-27.8 (2.9-23.3) 3 yr 3.7-32.4 (3.3-25.9) 4 yr 4.5-36.9 (3.8-28.7) 5 yr 5.2-41.4 (4.5-32) 6 yr 6-45.7 (5.1-35.5) 7 yr 6.9-50 (5.9-39.6) 8 yr 7.9-54.2 (6.8-44) 9 yr 8.9-58 (7.7-48.6) 10yr 9.8-61.4 (8.8-53.3) 11yr 10.9-64.2 (9.8-57.6) 12yr 11.8-66.2 (10.7-61.2) 13yr 12.6-67.3 (11.7-63.9) 14yr 13.2-67.6 (12.3-65.6) 15yr 13.6-67.1 (12.8-66.2) 16yr 14-65.8 (13.2-65.8) 17yr 14.3-63.9 (13.4-64.6) 18yr 14.3-61.8 (13.5-62.6) 19yr 14.3-59.3 (13.4-60.4) 20-29yr M: 11.3-56.6 F: (10-57.8) 30-39yr M: 9.6-32.8 F: (8.6-35.1) 40-49yr M: 7.9-27.5 F: (7.1-28.8) 50-59yr M: 6.4-25.8 F: (5.8-24.8)

If ukas accredited

Y NNUH